X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3523) 3523
male (2572) 2572
non-alcoholic fatty liver disease (2109) 2109
female (1966) 1966
fatty liver (1750) 1750
gastroenterology & hepatology (1673) 1673
animals (1539) 1539
liver diseases (1436) 1436
middle aged (1420) 1420
risk factors (1333) 1333
liver (1260) 1260
insulin-resistance (1209) 1209
adult (1204) 1204
obesity (1200) 1200
non-alcoholic fatty liver disease - etiology (1182) 1182
metabolic syndrome (1120) 1120
liver - pathology (1105) 1105
insulin resistance (1046) 1046
fibrosis (944) 944
liver - metabolism (910) 910
steatohepatitis (904) 904
prevalence (847) 847
mice (833) 833
nonalcoholic steatohepatitis (832) 832
non-alcoholic fatty liver disease - pathology (794) 794
steatosis (793) 793
hepatic steatosis (770) 770
non-alcoholic fatty liver disease - complications (757) 757
fatty liver - etiology (738) 738
non-alcoholic fatty liver disease - metabolism (722) 722
fatty liver-disease (718) 718
aged (707) 707
inflammation (659) 659
nafld (622) 622
nonalcoholic fatty liver disease (581) 581
biopsy (563) 563
obesity - complications (551) 551
analysis (544) 544
disease models, animal (540) 540
oxidative stress (535) 535
mice, inbred c57bl (523) 523
non-alcoholic steatohepatitis (522) 522
cirrhosis (514) 514
body mass index (502) 502
metabolism (490) 490
liver cirrhosis - etiology (488) 488
non-alcoholic fatty liver disease - epidemiology (478) 478
diabetes (476) 476
disease (475) 475
liver cirrhosis (471) 471
gastroenterology and hepatology (466) 466
non-alcoholic fatty liver disease - diagnosis (462) 462
fatty liver - pathology (457) 457
endocrinology & metabolism (454) 454
diet (447) 447
disease progression (444) 444
rodents (405) 405
diagnosis (398) 398
fatty liver - complications (395) 395
fatty liver - metabolism (393) 393
risk (392) 392
biomarkers - blood (390) 390
severity of illness index (387) 387
risk-factors (386) 386
diet, high-fat - adverse effects (384) 384
hepatology (384) 384
non-alcoholic fatty liver disease - blood (377) 377
nutrition & dietetics (373) 373
digestive system diseases (369) 369
nutritional and metabolic diseases (369) 369
hepatocellular-carcinoma (366) 366
adolescent (365) 365
association (355) 355
cross-sectional studies (347) 347
health aspects (347) 347
lipids (347) 347
liver - drug effects (343) 343
insulin (336) 336
non-alcoholic fatty liver disease - drug therapy (332) 332
nash (331) 331
liver cirrhosis - pathology (327) 327
research (327) 327
natural-history (323) 323
hepatitis (322) 322
biochemistry & molecular biology (321) 321
hepatocellular carcinoma (318) 318
development and progression (317) 317
fatty acids (313) 313
medicine & public health (313) 313
lipid metabolism (312) 312
epidemiology (308) 308
non-alcoholic fatty liver disease - genetics (307) 307
abridged index medicus (306) 306
retrospective studies (306) 306
cholesterol (305) 305
care and treatment (304) 304
pathogenesis (303) 303
rats (303) 303
gene expression (301) 301
physiological aspects (298) 298
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4698) 4698
Japanese (48) 48
Spanish (32) 32
Russian (30) 30
Portuguese (24) 24
French (21) 21
Chinese (19) 19
Korean (12) 12
German (11) 11
Hungarian (6) 6
Italian (6) 6
Ukrainian (6) 6
Norwegian (3) 3
Swedish (2) 2
Turkish (2) 2
Czech (1) 1
Dutch (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


World journal of gastroenterology : WJG, ISSN 1007-9327, 09/2017, Volume 23, Issue 36, pp. 6571 - 6592
In the last years new evidence has accumulated on nonalcoholic fatty liver disease (NAFLD... 
Type 2 diabetes | Screening | Clinical correlates | Pathogenesis | Biomarkers | Genetics | Liver histology | Nonalcoholic fatty liver disease | Diagnosis | Management | Metabolic syndrome | Epidemiology | LONG-TERM OUTCOMES | ATTENUATION PARAMETER CAP | SERUM URIC-ACID | FIBROSIS SCORING SYSTEMS | nonalcoholic fatty liver disease | HEPATOCELLULAR-CARCINOMA | Metabolic Syndrome | INSULIN-RESISTANCE | TOLL-LIKE RECEPTORS | CARDIOVASCULAR-DISEASE | GASTROENTEROLOGY & HEPATOLOGY | TYPE-2 DIABETES-MELLITUS | MULTIPARAMETRIC MAGNETIC-RESONANCE | Metabolic Syndrome - etiology | Liver - pathology | Prevalence | Humans | Non-alcoholic Fatty Liver Disease - etiology | Mass Screening - methods | Diet, Reducing | Exercise Therapy | Diabetes Mellitus, Type 2 - epidemiology | Diagnostic Imaging - methods | Liver Neoplasms - etiology | Liver Neoplasms - epidemiology | Dyslipidemias - blood | Liver - diagnostic imaging | Chenodeoxycholic Acid - therapeutic use | Vitamin E - therapeutic use | Diabetes Mellitus, Type 2 - etiology | Dyslipidemias - etiology | Metabolic Syndrome - epidemiology | Hypoglycemic Agents - therapeutic use | Liver Function Tests | Risk Assessment | Risk Factors | Biomarkers - analysis | Non-alcoholic Fatty Liver Disease - therapy | Hyperuricemia - etiology | Chenodeoxycholic Acid - analogs & derivatives | Hyperuricemia - blood | Dyslipidemias - epidemiology | Non-alcoholic Fatty Liver Disease - diagnosis | Hyperuricemia - epidemiology | Non-alcoholic Fatty Liver Disease - epidemiology | Review
Journal Article
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2018, Volume 155, Issue 2, pp. 443 - 457.e17
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2016, Volume 11, Issue 5, p. e0155163
Although non-alcoholic and alcoholic fatty liver disease have been intensively studied, concerning pathophysiological mechanisms are still incompletely understood... 
CONFERS SUSCEPTIBILITY | INDUCED HEPATIC STEATOSIS | BINDING-PROTEIN P62/IGF2BP2-2 | HIGH-FAT DIET | INSULIN-RESISTANCE | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | NONALCOHOLIC STEATOHEPATITIS | FREE-CHOLESTEROL | DENK BODY FORMATION | INDUCED OBESITY | Non-alcoholic Fatty Liver Disease - pathology | Liver - pathology | Species Specificity | Diet, High-Fat - adverse effects | Ethanol - administration & dosage | Non-alcoholic Fatty Liver Disease - etiology | Male | Mice, 129 Strain | Fatty Liver, Alcoholic - metabolism | Fatty Acids, Nonesterified - metabolism | Fatty Liver, Alcoholic - genetics | Subcutaneous Fat - metabolism | Dietary Fats - administration & dosage | Fatty Liver, Alcoholic - pathology | Weight Gain | Disease Models, Animal | Biomarkers - metabolism | Liver Function Tests | Disease Susceptibility | Non-alcoholic Fatty Liver Disease - genetics | Fatty Liver, Alcoholic - etiology | Liver - metabolism | Mice, Inbred C57BL | Non-alcoholic Fatty Liver Disease - metabolism | Cholesterol - metabolism | Mice, Inbred Strains | Subcutaneous Fat - pathology | Aspartate Aminotransferases - metabolism | Triglycerides - metabolism | Animals | Mice | Alanine Transaminase - metabolism | Fatty liver | Diet | Physiological aspects | Development and progression | Models | Research | Risk factors | Biotechnology | Animal models | Dehydrogenases | Liver | Lipids | Alcohol | Biochemistry | Biology | High fat diet | Fatty acid composition | Rodents | Hepatology | Physiology | Carbohydrates | Liver diseases | Ethanol | Inflammation | Metabolism | Gene expression | Fatty acids | Feeding | Steatosis | Nutrition research | Pathology | Natural products | Pharmacy | Insulin resistance | Pharmaceuticals
Journal Article